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Abstract The current study was a 7-year follow-up of 74
6–12 year old children with Pervasive Developmental
Disorder-Not Otherwise Specified. We examined the rates
and 7 year stability of comorbid psychiatric diagnoses as
ascertained with the Diagnostic Interview Schedule for
Children: Parent version at ages 6–12 and again at ages
12–20. Also, we examined childhood factors that predicted
the stability of comorbid psychiatric disorders. The rate of
comorbid psychiatric disorders dropped significantly from
childhood (81 %) to adolescence (61 %). Higher levels of
parent reported stereotyped behaviors and reduced social
interest in childhood significantly predicted the stability of
psychiatric comorbidity. Re-evaluation of psychiatric
comorbidity should be considered in clinical practice, since
several individuals shifted in comorbid diagnoses.
Keywords Autism spectrum disorder  Pervasive
developmental disorders  Comorbidity  Follow-up
Introduction
Psychiatric comorbidities in children with autism spectrum
disorder (ASD) are rather a rule than an exception (Ab-
dallah et al. 2011; De Bruin et al. 2007; Ghaziuddin et al.
1998; Joshi et al. 2010; Leyfer et al. 2006; Simonoff et al.
2008, 2013; Van Steensel et al. 2013). In 2007, we showed
that at least one comorbid psychiatric disorder was present
in 81 % of the children with Pervasive Developmental
Disorder-Not Otherwise Specified (PDD-NOS); 62 % had
a comorbid disruptive behavior disorder, and 55 % fulfilled
criteria of an anxiety disorder (De Bruin et al. 2007). Little
is however known about the stability of these childhood
psychiatric comorbidities in ASD towards adolescence and
adulthood. Adolescence is marked by many social, psy-
chological and physical changes in the individual. These
changes are often accompanied by an increase in emotional
or behavioral problems (Dahl 2004). The issues may be
amplified in ASD as a result of their particular difficulties
in adapting to change. Simonoff et al. (2013) have shown
that comorbid psychiatric symptoms in ASD are persistent
from childhood to adolescence, with domain-specific cor-
relations (i.e. among one specific type of symptoms, such
as anxiety) ranging from 0.33 to 0.58 across the period of
12–16 year old. However, the authors investigated the
stability of continuous questionnaire measures rather than
the stability of diagnostic categories. Information on the
stability of diagnoses based on in-depth interviews with
trained professionals can give us additional information on
the impact of problems on everyday functioning.
Therefore, the current prospective study firstly investi-
gated the stability from childhood into adolescence of
comorbid DSM-IV defined psychiatric disorders in chil-
dren with PDD-NOS on whom we previously reported
childhood comorbidity rates (De Bruin et al. 2007).
It is important to know which individuals are at risk of
persistent comorbid psychiatric disorders throughout ado-
lescence. For this purpose, it is important to examine fac-
tors in childhood that may predict the persistence of
comorbid disorders into adolescence. Several putative
predictors can be derived from the literature. Individual
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factors, such as age, gender, intelligence and type and/or
severity of ASD symptoms, might influence outcome in
adolescence. Firstly, the variation in age of onset varies
among comorbid disorders (e.g. Hepburn et al. 2014), thus,
age might explain differences in outcome. Secondly, gen-
der might also be an important predictive factor, since in
the general population, gender differences of psychiatric
disorders are often described. For example, anxiety
symptoms in adolescence and depression in late adoles-
cence are reported at higher prevalence in girls compared
to boys (Van Oort et al. 2009; Costello et al. 2003; Petersen
et al. 1991; Hankin et al. 1998). Disorders such as attention
deficit/hyperactivity disorder (ADHD) and conduct disor-
der (CD) are described to be more often present in boys
than in girls (Costello et al. 2003; Arnold 1996; APA
2000). Thirdly, intelligence might be a predictive factor
since children in the general population with an Intelli-
gence Quotient (IQ) below 80 tended to have more emo-
tional and behavioral problems compared to children with
an IQ above 80 (Dekker et al. 2002). In contrast, studies
regarding children with ASD often report high rates of co-
occurring disorders in individuals with both high and low
IQs (Simonoff et al. 2008; Leyfer et al. 2006). Fourthly,
type and severity of ASD symptoms might also influence the
comorbid disorders. In our previous cross-sectional study
we showed that children with PDD-NOS and both inter-
nalizing and externalizing disorders had more parent-rated
problems with executive functioning (i.e. orientation in
time, place and activity), more problems with tuning-into
the social situation and more stereotyped behaviors than
those with PDD-NOS without comorbid psychiatric disor-
ders (De Bruin et al. 2007). Moreover, individuals with
internalizing and externalizing disorders in childhood are at
risk for developing other co-occuring disorders during
adolescence (Goodwin et al. 2004; Bittner et al. 2007;
Bussing et al. 2010). However, more studies are needed to
evaluate the development of comorbid disorders in indi-
viduals with ASD. Therefore, in the current study, we also
investigated whether gender, age, IQ, type and severity of
parent-rated ASD symptoms, type of initial comorbid
psychiatric disorder, intermediate mental health care and




Participants were 74 individuals with PDD-NOS, who were
initially referred for diagnostic evaluation to the Department
of Child and Adolescent Psychiatry/Psychology of the
Erasmus Medical Center—Sophia Children’s Hospital
between July 2002 and September 2004. Eighty eight percent
of the sample was male, the mean IQ was 93 (SD = 16.96),
90.5 % had a Dutch nationality. 45 % of fathers and 46 % of
mothers had had a post-secondary school education; 84 % of
fathers and 57 % of mothers had had a paid job in the pre-
vious 2 years, and most were in paid employment at the time
of this study (83 % of fathers and 54 % of mothers). Of 54
participants, their living situation was known; 87 % were
living at home with their parent(s) at wave 2.
Inclusion criteria were: (1) meeting the research criteria
for PDD-NOS in childhood (n = 94; De Bruin et al. 2007;
Buitelaar et al. 1999), and (2) participation of the parents in
the Diagnostic Interview Schedule for Children: Parent
version ([DISC-IV-P], Ferdinand and Van der Ende 1998;
Shaffer et al. 2000), in childhood (n = 94, wave 1; age 6–12,
M = 9.02, SD = 1.81) and 7 years later, in adolescence
(n = 74, wave 2; age 12–20, M = 16.00, SD = 1.92). The
average follow-up time between the DISC-IV-P at wave 1
and wave 2 was 6.95 years (range 5.58–8.82 year; SD: 0.64).
The 74 individuals whose parents participated at both wave 1
and wave 2 did not significantly differ in terms of gender, age,
nationality, parental nationality, socio-economic status and
number of DISC-IV diagnoses from individuals whose parents
participated only at wave 1 (n = 94) (p[ .05). However,
individuals whose parents participated at both wave 1 and wave
2 had significantly higher IQ-scores (M = 92.96, SE = 16.96)
versus individuals whose parents only participated at wave 1
[M = 83.94, SE = 16.88; t(86) = -2.01, p = .05].
Measures
Diagnostic Interview Schedule for Children IV Parent
Version (DISC-IV-P)
The DISC-IV-P (Shaffer et al. 2000) is a structured parent
interview determining 1- and 12-month DSM-IV-TR (APA
2000) psychiatric disorders in children and adolescents. Parents
were interviewed by phone by trained and certified research
assistants. The DISC-IV-P was used to assess internalizing
disorders (i.e. anxiety and mood disorders) and externalizing
disorders (i.e. disruptive disorders) at wave 1 and 2 and was
scored using the internet software (Steenhuis et al. 2009) of the
Dutch translation of the DISC-IV-P (Ferdinand and Van der
Ende 1998). The anxiety disorder module consists of nine
disorders; social phobia (SoPh), separation anxiety disorder
(SAD), specific phobia (SP), panic disorder (PD), agoraphobia
(AG), generalized anxiety disorder (GAD), selective mutism
(SM), obsessive compulsive disorder (OCD) and posttraumatic
stress disorder (PTSD). The mood disorder module consists of
major depressive episode (MDD), dysthymia, and manic/hy-
pomanic episode. The disruptive behaviors are subdivided in
the DISC-IV-P in: ADHD, oppositional defiant disorder (ODD)
and CD.
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Children’s Social Behavior Questionnaire (CSBQ)
To examine whether the level and type of parent-rated
ASD symptoms in childhood (i.e. wave 1) was associated
with the stability of comorbidity, the CSBQ was used. The
CSBQ is a parental questionnaire, which contains 49 items
about a broad range of features that are typical for ASD
(Hartman et al. 2006; Luteijn et al. 1998). The items are
scored on a three-point scale (i.e. 0: behavior does not
apply; 1: behavior sometimes or somewhat applies; 2:
behavior clearly or often applies to the child). The CBSQ
consists of six subscales; (1) ‘‘not optimally tuned to the
social situation’’, (2) ‘‘reduced contact and social interest’’,
(3) ‘‘orientation problems in time, place or activity’’, (4)
‘‘difficulties in understanding social information’’, (5)
‘‘stereotyped behavior’’ and (6) ‘‘fear of and resistance to
changes’’. Good test–retest, inter-rater reliability and
internal consistency have been reported for this measure
(Hartman et al. 2006). Across our sample, internal con-
sistency of CBCQ data was good, with Cronbach’s alpha’s
ranging from 0.79 to 0.88.
Intelligence Quotient (IQ)
To examine whether IQ in childhood (i.e. wave 1) was
associated with the stability of comorbidity, the Wechsler
Intelligence Scale for Children-Revised (WISC-R; Wech-
sler 1974) was administered. This instrument comprises a
verbal scale (VIQ) and a performance scale (PIQ) together
forming a total scale (TIQ). The Dutch version of the
WISC-R has been demonstrated to be sufficiently reliable
and valid (Van Haasen et al. 1986).
Intermediate Use of Mental Health Care and Medication
To assess the use of mental health care and medication
between wave 1 and 2, a parent questionnaire was
administered at wave 2 (Amone-P’Olak et al. 2010). Eight
questions concerned use of mental health care with regard
to emotional and/or behavioral problems of the child.
These items were scored as 0 (i.e. not used) or 1 (i.e. used).
If any of these items was scored 1, the variable ‘mental
health care’ was scored 1. Parents were also asked if their
child had used psychotropic medication in the past
2 weeks. This variable was also scored as 0 (i.e. not used)
or 1 (i.e. used).
Self-Reported Emotional and Behavioral Problems (Youth
Self Report; YSR)
The YSR is an instrument of the Achenbach System of
Empirically Based Assessment (ASEBA) that has good
reliability and validity (Achenbach and Rescorla 2001), and
has been used previously with cognitively able individuals
with ASD (Schroeder et al. 2011; Hurtig et al. 2009).
Adolescents rate their behavior over the preceding
6 months, items being scored on a three-point scale, with
responses: 0 = not true, 1 = somewhat or sometimes true,
2 = very true or often true. The problem items are scored on
empirically based syndromes that were derived by factor
analyses. In the current study, the YSR was only adminis-
tered at wave 2, and we analyzed scores on the following
scales: Anxious/Depressed, Withdrawn/Depressed, Somatic
Complaints, Attention Problems, Rule-Breaking Behavior
and Aggressive Behavior (i.e. the scales that are most sim-
ilar to the content of the DISC-P). T-scores of 65 or higher
reflect scores in the subclinical range, while t-scores of 70 or
higher reflect scores in the clinical range.
Data Analysis
Firstly, the rates of comorbid psychiatric disorders were
calculated at wave 1 and wave 2. The significance of
putative changes in the prevalence rates was tested using
McNemar tests. To investigate the stability of comorbid
psychiatric disorders from childhood to adolescence, we
made a cross-table of the presence or absence of comorbid
disorders at wave 1 and wave 2 (i.e. proportions of indi-
viduals in the following groups: 1: ‘‘persistent presence’’,
2: ‘‘from presence to absence’’, 3: ‘‘from absence to pres-
ence’’ and 4: ‘‘persistent absence’’). To graphically illus-
trate whether stability was domain-specific, the number of
individuals with either continuous or discontinuous disor-
ders from wave 1 to wave 2 were demonstrated.
To examine whether gender, age, IQ, level and type of
parent-rated ASD symptoms (CSBQ scores), intermediate
mental health care and medication were associated with the
stability of psychiatric disorders, we compared the group
with persistent disorders (n = 38, ‘‘persistent presence’’)
with the group that changed from disorder to no disorder
(n = 22, ‘‘from presence to absence’’) and the group with
persistent absence of disorders (n = 7, ‘‘persistent
absence’’) with the group that changed from no disorder to
disorder (n = 7, ‘‘from absence to presence’’). Compar-
isons were performed using t-tests for continuous variables
(i.e. IQ, age, CSBQ scores) and Chi Square tests for cat-
egorical variables (i.e. gender, mental health care use and
the use of psychotropic medication). For the smaller groups
‘‘persistent absence’’ and ‘‘from absence to presence’’, non-
parametric testing (i.e. Mann–Whitney U test and Binomial
test) was used.
To be able to further interpret the parent-reported DISC
data in the light of self-reported emotional and behavioral
problems in adolescence, we post hoc explored the pro-
portions of individuals who scored in the subclinical (Ct65)
and clinical (Ct70) range of the YSR at wave 2.
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Results
Prevalence of Comorbid Psychiatric Disorders
in Childhood and Adolescence
The prevalence of all separate comorbid disorders at wave 1
and wave 2 are presented in Table 1. Internalizing disorders
significantly decreased over time; 60 % of the individuals in
childhood met criteria for at least one internalizing disorder, in
adolescence this rate dropped to 35 % [McNemar; x2
(n = 74) = 10.32, p = .001]. Note that especially the rate of
anxiety disorders, significantly decreased from childhood (i.e.
55 %) to adolescence (i.e. 31 %) [McNemar; x2
(n = 74) = 10.32, p = .001]; the rate of mood disorders
approximately stayed the same. The rates for externalizing
(i.e. disruptive) disorders did not significantly change from
childhood (i.e. 61 %) to adolescence (i.e. 51 %). Overall, the
number of individuals who had a comorbid psychiatric dis-
order significantly changed from childhood to adolescence
[McNemar; x2 (n = 74) = 6.76, p = .01]; during childhood,
81 % of the individuals had one or more comorbid psychiatric
disorder, during adolescence at least one comorbid psychiatric
disorder was present in 61 % of the individuals.
Stability of Comorbid Psychiatric Disorders
Figure 1 shows the proportions of individuals in the fol-
lowing groups (1) ‘‘persistent presence’’, (2) ‘‘from pres-
ence to absence’’, (3) ‘‘from absence to presence’’ and (4)
‘‘persistent absence’’. Of the individuals who had at least
one comorbid psychiatric disorder in childhood (n = 60),
63 % still had at least one comorbid psychiatric disorder in
adolescence (n = 38), whereas 37 % of the individuals no
longer met criteria for a comorbid psychiatric disorder in
adolescence (n = 22). Of the individuals who had no
comorbid psychiatric disorder in childhood (n = 14), 50 %
(n = 7) stayed free of a comorbid psychiatric disorder in
adolescence, whereas 50 % (n = 7) of the individuals
developed at least one comorbid psychiatric disorder in
adolescence.
Table 1 Prevalence of comorbid disorders according to the DISC-IV-P (n = 74)
Disorder Wave 1 (age 6–12)
% of individuals
Wave 2 (age 12–20)
% of individuals
p Transitions in diagnosis
Stablea Out ofb Intoc
n n n
Anxiety disorders 55.4 31.1 0.001 18 23 5
Social phobia 10.8 1.4 0.02 1 7 0
Separation anxiety disorder 6.8 4.1 0.69 1 4 2
Specific phobia 40.5 25.7 0.04 12 18 7
Agoraphobia 5.4 2.7 0.69 0 4 2
Panic disorder without agoraphobia 1.4 0.0 1.00 0 1 0
Panic disorder with agoraphobia 0.0 1.4 1.00 0 0 1
Generalized anxiety disorder 6.8 4.1 0.73 0 5 3
Selective mutism 0.0 0.0 – 0 0 0
Obsessive compulsive disorder 6.8 8.1 1.00 0 5 6
Posttraumatic stress disorder 0.0 1.4 1.00 0 0 1
Mood disorders 12.2 10.8 1.00 3 6 5
Major depression 8.1 10.8 0.73 3 3 5
Dysthymic disorder 2.7 0.0 0.50 0 2 0
Mania 4.1 1.4 0.63 1 3 1
Hypomania 2.7 0.0 0.50 0 2 0
Disruptive disorders 60.8 51.4 0.28 26 19 12
ADHD, combined type 20.3 8.1 0.05 2 13 4
ADHD, inattentive type 13.5 25.7 0.08 4 6 15
ADHD, hyperactive/impulsive type 10.8 5.4 0.39 0 8 4
Oppositional defiant disorder 35.1 27.0 0.29 12 14 8
Conduct disorder 9.5 2.7 0.18 0 7 2
Bold values are statistically significant (p\ 0.05)
a Identical = Participants had the same diagnosis at T1 and at T2
b Out of = Participants did have the diagnosis at T1, but no longer at T2
c Into = Participants did not have the diagnosis at T1, but did have the diagnosis at T2
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Figure 2 illustrates the domain-specific stability; the
amount of individuals with continuous or discontinuous
(i.e. other type of) disorders from wave 1 to wave 2.
Predictors of Stability
The childhood characteristics of individuals in the ‘‘per-
sistent presence’’ group (n = 38) versus the ‘‘presence to
absence’’ group (n = 22) were compared to examine fac-
tors associated with stability of comorbid psychiatric dis-
orders (Table 2). No significant differences were found
regarding age, gender, IQ, intermediate mental health care
and psychotropic medication.
As for level and type of symptoms of ASD, individuals
with persistent comorbidity had significant more parent-
reported stereotyped behaviors [t(53.465) = 3.66,
p = .001, R2N = 0.226] and reduced contact and social
interest [t(57) = 2.15, p = .04, R2N = 0.10] in childhood,
than individuals who lost their comorbid psychiatric diag-
nosis during adolescence.
To further clarify this finding, a post hoc test was per-
formed to reveal possible predictors specific for persistent
externalizing versus persistent internalizing disorders. In
both cases, only parent-reported stereotyped behavior was
a significant predictive factor for persistence of the same
psychiatric comorbidities [i.e. respectively (t(40) =
-2.953, p = .005); (t(39) = -3.287, p = .002)].
The childhood characteristics of the ‘‘persistent
absence’’ group (n = 7) were compared to the ‘‘absent to
present’’ group (n = 7) on factors associated with stability
of comorbid psychiatric disorders (Table 2). No significant
differences were found in age, gender, IQ, level or type of
ASD symptomology, intermediate mental health care or
use of psychotropic medication.
Self-Reported Emotional and Behavioral Problems
Table 3 shows the proportions of individuals who scored in
the subclinical (t65–t70) and clinical (Ct70) range of the
YSR at wave 2.




















































Fig. 2 Transitions in type of comorbid psychiatric disorders from childhood to adolescence. This figure shows the different types of transitions
from T1 comorbid diagnoses (left circle in each square) to T2 comorbid diagnoses (right circles in each square)
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Discussion
The current follow-up study examined stability and pre-
dictors of comorbid psychiatric disorders in individuals
with PDD-NOS. Firstly, we examined the rates of comor-
bid psychiatric disorders in childhood and in adolescence.
The rates of individuals who had one or more comorbid
psychiatric disorder in childhood (81 %) and adolescence
(61 %) were similar to rates found in previous studies
(Abdallah et al. 2011; Ghaziuddin et al. 1998; Leyfer et al.
2006; Simonoff et al. 2008; Van Steensel et al. 2013). In
general, psychiatric comorbidity was rather stable (63 %);
individuals who already had at least one comorbid psy-
chiatric classification in childhood, usually still had at least
one comorbid psychiatric classification in adolescence.
One previous study concerning the stability of symptom
levels of other psychiatric disorders from childhood to
adolescence in a sample of individuals diagnosed with
ASD found that symptoms of co-occurring psychiatric
problems were persistent in individuals with ASD from
childhood to adolescence (Simonoff et al. 2013). The
current study added to that work by showing that both other
psychiatric symptoms and other categorical psychiatric
diagnoses can persist from childhood to adolescence.
Changes in prevalence rates and transitions between types
of comorbidity were examined and are discussed below.
Due to the limited sample size, domain-specific stability of
psychiatric comorbidity could not be tested.
The prevalence of one or more anxiety disorder in
individuals with PDD-NOS, according to the DISC-IV-P,
was significantly higher in childhood (55 %) than in ado-
lescence (31 %). In the general population, also a decrease
in anxiety from early to middle adolescence has been found
(e.g. Van Oort et al. 2009), suggesting a similar develop-
mental process. The rates for anxiety disorders in the
individuals with PDD-NOS in the current study were quite
high, although even higher rates (84 %) were reported in
the literature (Muris et al. 1998). In the current study,
among all anxiety disorders, the highest prevalence was
found for SP at both assessment waves; 41 % in childhood,






















Gender: % boys 84 % 96 % 0.19 71 % 100 % 0.38
Age (SD) 9.06 (1.66) 8.94 (2.10) 0.83 9.29 (2.55) 9.71 (1.57) 1.00
IQ (SD) 91.65 (17.20) 97.79 (18.33) 0.22 92.57 (16.77) 87.14 (10.96) 0.54
CSBQ scores (SD)
Not optimally tuned to social situation 13.76 (5.10) 12.24 (5.49) 0.29 9.00 (6.33) 8.57 (5.74) 0.90
Reduced contact and social interest 10.05 (5.55) 7.05 (4.54) 0.04 9.71 (5.77) 7.71 (3.45) 0.46
Orientation problems in time, place or
activity
8.33 (3.73) 6.55 (4.64) 0.11 6.86 (3.76) 5.71 (1.89) 0.90
Difficulties in understanding social
information
7.65 (4.07) 7.00 (3.81) 0.55 8.29 (3.50) 7.71 (3.15) 0.90
Stereotyped behavior 5.67 (3.90) 2.60 (2.37) 0.001 3.14 (4.63) 3.17 (2.86) 0.84
Fear of and resistance to changes 3.92 (2.03) 3.27 (2.41) 0.28 2.29 (1.98) 3.29 (1.89) 0.26
Mental health care 81 % 91 % 0.34 86 % 86 % 0.21
Medication 60 % 38 % 0.12 29 % 29 % 1.00
Bold values are statistically significant (p\ 0.05)
Table 3 Self-reported
emotional and behavioral
problems (n = 66) at wave 2
YSR scale % (Sub)clinical rangea
Anxious depressed 15.2 % (of which n = 6 subclinical, and n = 4 clinical)
Withdrawn depressed 18.2 % (of which n = 10 subclinical, and n = 2 clinical)
Somatic complaints 6.1 % (of which n = 0 subclinical, and n = 4 clinical)
Attention problems 18.2 % (of which n = 6 subclinical, and n = 6 clinical)
Rule breaking behaviors 4.5 % (of which n = 1 subclinical, and n = 2 clinical)
Aggressive behaviors 12.1 % (of which n = 5 subclinical, and n = 3 clinical)
a Subclinical range = t65–t70; clinical range Ct70
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and 26 % in adolescence. This is in line with previous
studies that also described SP as the most common anxiety
disorder in children with ASD (Leyfer et al. 2006; Muris
et al. 1998; Van Steensel et al. 2013) The current findings
add to the existing literature, by showing that also in
adolescence, SP is the most common anxiety disorder
among individuals with ASD, although a significant drop
was also found with 18 cases no longer meeting criteria for
this disorder. Possibly, the finding of highly prevalent SP
could be explained by the fact that we—and previous
studies—used the parent as the informant; i.e. specific
phobias might be most noticeable to parents, especially in
childhood. For this reason, we also explored self-reported
anxiety levels. These preliminary findings did not suggest
higher self-reported levels of anxiety in adolescence. Yet
clearly, further studies using self-reported anxiety are
needed to clarify the most prevalent types of anxiety in
children and adolescents with ASD (Muris et al. 1998).
The rate of MDD increased slightly from 8 % in
childhood to 11 % in adolescence. These rates are in line
with those known from the literature, although higher (i.e.
16 %) and much lower rates (i.e. 1 %) have also been
reported among individuals with ASD (Leyfer et al. 2006;
Simonoff et al. 2008; Mazefsky et al. 2011; Van Steensel
et al. 2013; Witwer and Lecavalier 2010). In the general
population, also an increase in depression from childhood
to adolescence has been found (Maughan et al. 2013),
suggesting a similar developmental process.
The rate of comorbid ADHD decreased from childhood
(45 %) to adolescence (39 %). These relatively high rates
are in line with previous studies (Goldstein and Schwebach
2004; Leyfer et al. 2006; Mazefsky et al. 2011), although
lower rates have also been reported among individuals with
ASD (Abdallah et al. 2011; Hanson et al. 2013; Simonoff
et al. 2008; Van Steensel et al. 2013). The current study
found a decrease for the hyperactivity type of ADHD and
the combined type of ADHD in individuals with PDD-NOS
from childhood to adolescence, but an increase for the
inattentive type of ADHD in adolescence, with 15 new
cases in adolescence. This change in the occurrence of
ADHD in individuals with PDD-NOS is in line with the
suggested trajectory of development of ADHD with
hyperactivity at preschool age, more normoactive behavior
during the early school years and a tendency to hypoac-
tivity in early adolescence (Gillberg and Billstedt 2000). In
adolescence, transition to secondary education increases
attentional demands and peer pressures, with the potential
to amplify previously unnoticed problems.
In the current study, criteria for ODD were met for 35 %
of the individuals in childhood and 27 % of the individuals
in adolescence. Simonoff et al. (2008) found similar rates
(28 %) with the DISC in their study among 10–14 year old
individuals with ASD, although much lower (i.e. 7 %;
Leyfer et al. 2006) as well as higher (i.e. 75 %; Witwer and
Lecavalier 2010) rates of ODD have been reported in
studies that used other diagnostic instruments. Criteria for
CD were met for 10 % of the individuals in childhood and
3 % of the individuals in adolescence. The rate in adoles-
cence is similar to the rate (3 %) found in the study of
Simonoff et al. (2008) among 10–14 year old individuals
with ASD, although much higher rates (i.e. 22 %) are
reported among 3–17 year olds with ASD (Joshi et al.
2010). All individuals with CD in the current study also
met the criteria for ODD at both T1 and T2.
Taken together, the overall prevalence of parent-reported
psychiatric comorbidity decreased from childhood to ado-
lescence. Variation in the prevalence of comorbid disorders
across different studies may be explained by methodological
differences in aspects such as methods of assessment and
diagnosis, and how samples were constituted (i.e. differ-
ences in levels and types of care in different institutions).
Our own data showed no particular transitions from one type
of comorbidity to another; only 2 cases shifted from having
an internalizing to an externalizing diagnosis, and one from
an externalizing to an internalizing one. Although our
dataset is limited, cross-domain transitions seem infrequent,
and domain stability seems most common.
The current study suggested two predictors of
stable psychiatric comorbidity from childhood to adoles-
cence. Children with stable psychiatric comorbidity
showed a higher childhood level of parent-reported
stereotyped behavior and reduced contact and social
interest. Post-hoc analyses also showed that parent-re-
ported stereotyped behaviors were predictive for the per-
sistent presence of either internalizing or externalizing
disorders. Thus, our preliminary findings suggest that
parent-reported stereotyped behaviors might be an indica-
tion for persistent comorbidity. There were no significant
predictors for the persistent absence of comorbidity,
although there probably was a lack of power to detect
these, since these groups were very small. To our knowl-
edge, no previous studies investigated childhood predictors
of comorbidity in adolescence, so further research is nee-
ded to corroborate our findings.
Taken together, although the stability rate of any
comorbid psychiatric classification was considerable
(63 %), re-evaluation of psychiatric comorbidity in ado-
lescence should be considered in clinical practice, since a
reasonable amount of individuals no longer meet diag-
nostic criteria for a comorbid classification in adolescence
or shifted from one comorbid diagnosis to another.
Reduced social interest and stereotyped behavior as rated
by parents might be considered as indicators of
stable psychiatric comorbidity.
PDD-NOS itself can show different developmental tra-
jectories. In the current literature, there are studies that
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show relative stability of ASD diagnosis (Jo´nsdo´ttir et al.
2007; Takeda et al. 2005); but also studies showing shifts
within the spectrum and studies showing that some indi-
viduals appear to move out of the spectrum (Daniels et al.
2011; Kleinman et al. 2008; Turner and Stone 2007; for a
review, please see Woolfenden et al. 2012). Of the 74
children with PDD-NOS participating in this last study, 22
no longer met criteria for PDD-NOS in adolescence. There
are also children that don’t meet criteria for ASD at a
young age, but who do at an older age (i.e. in our larger
cohort of 246 clinical referrals, 16 children did not meet
PDD-NOS criteria in childhood, but did so in adolescence).
Changes in comorbidity need to be interpreted in the
context of these possible changes within ASD. For details
on the stability of ASD within this sample, see Louwerse
et al. (2015). Further research into the intertwined devel-
opment of ASD symptomology and autistic and co-occur-
ring psychiatric problems is warranted.
Our sample of children was diagnosed with PDD-NOS. But
one may wonder how these findings apply to individuals
diagnosed with ASD using current DSM 5 criteria. The chil-
dren in our sample also were part of a larger study on phe-
notypic profiles of children with PDD (Greaves-Lord et al.
2013). This study has found that about 30 % of the sample had
a profile more in line with the more recent DSM-5 diagnosis of
Social (Pragmatic) Communication Disorder. The reader
should interpret our findings against this background.
Our wave 2 YSR self-report data was used to provide
information on adolescents’ internalizing comorbidities
through post hoc exploration. Contrary to our expectations
we found lower self-reported rates of anxiety rates
(15.2 %) than parent-reported DISC-P wave 2 rates
(31.1 %). We had expected to see higher self-reported than
parent-reported rates of internalizing problems, given that
adolescents might not openly share these emotions with
their parents. In line with expectations, we found a some-
what higher rate of self-reported depressive symptoms
(18.2 %—in the subclinical range) when compared to the
parent-reported DISC-P wave 2 rate of 10.8 %. DISC-P
data cannot be directly compared to YSR data due to the
rather different properties of these instruments, and the lack
of comparative research on these two measures. We hope
these data provide some background information that helps
to broaden the picture from our main analyses. Further
research would be needed to profile the longitudinal tra-
jectories of self-reported comorbidities in this group.
As discussed above, the current findings presented are
quite preliminary, and should be interpreted against the
background of some methodological limitations. Results are
based on parental interviews in a relatively small sample of
individuals with PDD-NOS with an average to high IQ who
were referred to one particular center, thus clinicians should
make careful considerations regarding their own specific
clients, and further research on samples with more pheno-
typic variation in ASD severity and cognitive ability using
multiple informants is needed. Also, only information on
current medication in adolescence was obtained, without
further details on medication history. Therefore, our finding
that medication was not associated with later comorbidity
should be further scrutinized in future research. Finally,
since only 12 participants of the current sample were
18 years or older at the time of wave 2 data collection, it is
not yet possible to shed further light on the adult outcomes
of the current sample. Development from adolescence into
adulthood is accompanied by many challenges regarding
societal functioning (i.e. community and social participation,
such as obtaining a job, living independently, and building
intimate relationships). In a study of Myers et al. (2015), it
was found that co-occurring behavioral difficulties in ado-
lescents with ASD were associated with increased risk of
social isolation in adolescence, but not with social or com-
munity participation in adulthood. This study did not
investigate behavioral or emotional difficulties in adulthood,
but one might assume that comorbid emotional and/or
behavioral problems in adulthood may be affected by neg-
ative social/community outcomes, and may thus become
more problematic over time. Future research is warranted to
further examine the trajectories and determinants of
comorbid psychiatric disorders of individuals with ASD into
adulthood and later life.
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